PS Ratio:
442.48-4.12(-0.92%)Summary
- As of today, XENE price to sales ratio is 442.48, with a fall of -4.12 (-0.92%) during the most recent trading session on October 21, 2025.
- XENE PS ratio is now -97.87% below its all-time high of 20.78 thousand.
Performance
XENE PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
XENE PS Ratio Trends
| PeriodPeriod | PS RatioPS Ratio | PricePrice | Market CapMarket Cap | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | -0.9% | -0.9% | -0.9% | 0.0% |
| 1M1 Month | +16.5% | +16.5% | +16.5% | - |
| 3M3 Months | +37.0% | +36.7% | +37.0% | 0.0% |
| 6M6 Months | +24.9% | +24.0% | +24.9% | - |
| YTDYTD | - | +9.8% | +10.8% | - |
| 1Y1 Year | - | -2.6% | -1.0% | +100.0% |
| 5Y5 Years | +3553.8% | +309.9% | +803.2% | -75.3% |
XENE PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 446.60 | -0.9% | 375.45 | +17.9% |
| 3M | 3-Month | 446.60 | -0.9% | 310.84 | +42.4% |
| 6M | 6-Month | 446.60 | -0.9% | 291.49 | +51.8% |
| 1Y | 1-Year | 446.60 | -0.9% | 288.30 | +53.5% |
| 3Y | 3-Year | 19.31K | -97.7% | 156.99 | +181.8% |
| 5Y | 5-Year | 19.31K | -97.7% | 10.94 | +3944.6% |
| All-Time | All-Time | 20.78K | -97.9% | 4.45 | +9843.4% |
XENE PS Ratio History
| Date | Value |
|---|---|
| 2025 | 442.48(+69.2%) |
| 2022 | 261.59(+199.0%) |
| 2021 | 87.49(+422.6%) |
| 2020 | 16.74(-69.0%) |
| Date | Value |
|---|---|
| 2019 | 54.02(-67.0%) |
| 2017 | 163.49(+113.5%) |
| 2016 | 76.58(+932.1%) |
| 2015 | 7.42(-24.8%) |
| 2014 | 9.87 |
FAQ
- What is Xenon Pharmaceuticals Inc. price to sales ratio?
- What is the all-time high PS ratio for Xenon Pharmaceuticals Inc.?
What is Xenon Pharmaceuticals Inc. price to sales ratio?
The current PS ratio of XENE is 442.48
What is the all-time high PS ratio for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high price to sales ratio is 20.78K